Location History:
- Elermore Vale, New South Wales, AU (2006)
- Elermore Vale, AU (2008 - 2016)
- New South Wales, AU (1999 - 2018)
Company Filing History:
3 out of 6 
1 out of 3 
1 out of 1 Years Active: 1999-2018
Title: The Innovative Contributions of Margaret Lorraine Dunkley
Introduction
Margaret Lorraine Dunkley is a prominent inventor based in New South Wales, Australia. She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of six patents to her name, her work focuses on addressing chronic obstructive pulmonary disease and asthma.
Latest Patents
Among her latest patents, Dunkley has developed non-typeable vaccines that are useful for the treatment of chronic obstructive pulmonary disease and asthma in patients. One notable aspect of her work includes a monobacterial vaccine, which utilizes specific bacterial strains for effective treatment. Additionally, she has provided methods for the prophylaxis or treatment of asthma, which involve administering an effective amount of a non-typeable (NTHi) vaccine, typically in the form of an oral whole killed NTHi vaccine.
Career Highlights
Dunkley has worked with several companies throughout her career, including Hunter Immunology Limited and Auspharm International Limited. Her innovative research and dedication to improving patient outcomes have established her as a key figure in her field.
Collaborations
Dunkley has collaborated with notable individuals such as Robert Llewellyn Clancy and Allan William Cripps, further enhancing her contributions to immunology and vaccine development.
Conclusion
Margaret Lorraine Dunkley's work in vaccine development has made a significant impact on the treatment of chronic respiratory diseases. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient health outcomes.